Abstract: In many cases after degaussing the field distribution in a magnetic material there may be regions within the magnetic material that have ordered domains that contribute a remnant field. There is the need to reduce or eliminate non-uniform fields within a volume of interest left after degaussing a magnetic shield. Degaussing coils surrounding a metal shield can be used to favorably order magnetic domains within the material to counteract the remnant fields left behind following imperfect degaussing. The remnant field value can be measured and a small current may be applied through the degaussing coils. After removing the current, the field can be measured again and a higher current may be applied again through the coils. Repeated applications of currents and field measurement will progressively order domains in the direction of the applied field, resulting in a reduction of the net field and lower field gradient across the volume of interest.

Abstract: A battery comprises: at least one electrical energy storage cell; an enclosure in which the at least one electrical energy storage cell is housed, the enclosure having a bottom made from a material with low thermal conductivity having at least one flow channel for a cooling fluid; a thermal plate made from a material with a high thermal conductivity, laying down on the bottom the thermal plate being in thermal contact with the at least one electrical energy storage cell; and a cradle, facing the bottom and separated from the bottom by a space.

Abstract: A continuous sol-gel process for producing silicate-containing glasses and glass ceramics is proposed, comprising the following steps: (a) continuously feeding a silicon tetraalkoxide, a silicon alkoxide with at least one non-alcoholic functional group and an alcohol into a first reactor (R1), and at least partially hydrolyzing by the addition of a mineral acid to obtain a first product stream (A); (b) continuously providing a second product stream (B) in a second reactor (R2) by feeding a metal alkoxide component or continuously mixing an alcohol and a metal alkoxide component; (c) continuously mixing product streams (A) and (B) in a third reactor (R3) for producing a presol to obtain a third product stream (C); (d) continuously adding water or a diluted acid to the product stream (C) to obtain a sol (gelation); (e) continuously filling the emerging sol into molds to obtain an aquagel; (f) drying the aquagels to obtain xerogels; (g) sintering the xerogels to obtain silicate-containing glasses and glass cera

Abstract: The present invention concerns a composition comprising at least three peptides derived from Mycobacterium tuberculosis antigen Rv2626c, its use in the diagnostic of latently infected Mycobacterium tuberculosis (LTBI) subjects, corresponding methods of use and kits.

Abstract: An object of the present invention is to provide a lyophilized formulation having improved storage stability of hepatic growth factor compared to conventional lyophilized formulations. The present invention provides a lyophilized formulation comprising (1) a hepatic growth factor, (2) trehalose and (3) one or more compounds selected from the group consisting of arginine, histidine, lysine, meglumine, glutamic acid, aspartic acid, proline, creatine, creatinine, tris(hydroxymethyl)aminomethane, and pharmaceutically acceptable salts thereof.

Abstract: The invention provides compounds of formula (I): where the variables are defined in the specification, or a pharmaceutically-acceptable salt thereof, that are useful as JAK kinase inhibitors. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat respiratory diseases, and processes and intermediates useful for preparing such compounds.

Abstract: A method of preparing a radioactive yttrium salt particle suspension comprising multiple steps comprising: using a hydrothermal process wherein a solution of soluble yttrium salt, from the group of yttrium chloride, yttrium nitrate, yttrium sulfate, and yttrium bromide is combined with a solution of sodium phosphate having a stoichiometric excess of phosphate and a preferred pH when combined.

Abstract: A fabric softener composition comprising: a. 1 to 20 wt. % ionic compound of general formula I: (I) b. 0.1 to 30 wt. % perfume; and c. Water.

Abstract: The present disclosure relates to circuits, systems, and methods of operation for a memory device. In an example, a memory device includes a plurality of memory cells, each memory cell having a variable impedance that varies in accordance with a respective data value stored therein; and a read circuit configured to read the data value stored within a selected memory cell based upon a variable time delay determination of a signal node voltage change corresponding to the variable impedance of the selected memory cell.

Abstract: Disclosed is a method of determining a bacterial strain suitable for treating a human skin dysbiotic condition, comprising a step of doing network analysis by a computer to determine the connectivity of said bacterial strain with at least a second bacterial strain in a dysbiotic condition as well as a non-dysbiotic condition, wherein there is difference in said connectivity between said dysbiotic condition and said non-dysbiotic condition wherein said connectivity means a positive correlation or negative correlation and further wherein said network is generated by co-occurrence analysis of abundance of said bacterial strain and said second bacterial strain by DNA sequencing by following 16s rRNA amplicon or whole genome sequencing method.

Abstract: A frozen confection comprising sugars in a total amount S of less than 21 wt % and amino acids in a total amount A of at least 0.75 wt %, wherein the frozen confection comprises at least one amino acid selected from: alanine, arginine, glycine, lysine, proline, serine, and dipeptides thereof.

Abstract: A method is provided for configuring a touch sensor controller coupled to a touch panel and a host computing device. The method includes receiving, by the controller, first input for starting a configuration mode of operation. The first input may be received independent of the host computing device. The controller initiates the configuration mode of operation responsive to the first input. The controller receives at least one second input via the touch panel for configuring at least one operational setting of the controller. The method also includes configuring, by the controller, the at least one operational setting according to the received at least one second input.

Abstract: A tire testing apparatus performs the test by rotating a tire while the tire is in contact with a drum. A plurality of sensors are provided on the outer circumferential surface of the drum and are arranged side by side along a widthwise direction of the drum, thereby measuring the ground contact forces at the ground contact position with the tire. A calculation unit obtains, based on the ground contact forces measured by the sensors, a displacement amount Dy of the ground contact position in the widthwise direction and a change amount ?Fy of the ground contact force Fy in the widthwise direction which corresponds to the displacement amount Dy, thereby calculating the lateral stiffness sharing rate Ky rib on the basis of the displacement amount Dy and the change amount ?Fy.

Abstract: Provided is an apparatus for use with a coffee maker, the apparatus. The apparatus may include a cup shelf and a track disposed vertically, the track comprising a rail, the rail having a top rail portion and a bottom rail portion. The apparatus may include a switch having a hinge pin and a hook pin, where the switch is configured to be pressed by a user, where the cup shelf is vertically movable, and where the hook pin is configured to interface with the top rail portion.

Abstract: The disclosure provides thiol-containing alkyl fatty acid and vitamin D compound formulations for intra-venous, parenteral or oral administration. The compositions of the present technology have optimal controlled bioavailability and are useful for treating metabolic dysfunctions such as pre-diabetes, Metabolic Syndrome and diabetes. Also provided are methods of treatment comprising the daily administration of the disclosed thiol-containing alkyl fatty acid formulations alone or in combination with the disclosed vitamin D compound formulations.

Abstract: Heat treatment system and methods to decontaminate ballast fluid includes ballast tank(s) each having a temperature sensor. A heat source transfers heat to ballast fluid when circulated therethrough. Diverter valves provide selective direction of fluid flow to either the onboard heat source or external auxiliary heat source when connected. A pump moves ballast fluid between the ballast tank(s) and the heat source, recirculating ballast fluid for iterative heating. The temperature sensor provides ballast fluid temperature information in the ballast tank(s). Recirculation is stopped when ballast fluid meets predetermined ballast temperature conditions. A display provides decontamination status to an operator. A control unit monitors all sensors, valves and pumps to coordinate the performance of the heat treatment process and provide history report confirming decontamination.

Abstract: The invention provides compounds of formula (I): or pharmaceutically-acceptable salts thereof, that are inhibitors of Janus kinases. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat inflammatory and autoimmune skin diseases.